Adrian Kilcoyne - 08 Mar 2022 Form 4 Insider Report for HUMANIGEN, INC

Role
Chief Medical Officer
Signature
/s/ Henry Madrid, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
08 Mar 2022
Net transactions value
+$31,610
Form type
4
Filing time
14 Mar 2022, 16:37:16 UTC
Previous filing
14 Jan 2022
Next filing
29 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HGEN Common Stock Purchase $17,710 +7,000 $2.53 7,000 08 Mar 2022 Direct F1
transaction HGEN Common Stock Purchase $13,900 +5,000 +71% $2.78 12,000 09 Mar 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.52 to $2.53, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.75 to $2.80, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Exhibit List: Exhibit 24 -- Power of Attorney